Pure Bioscience, Inc. (PURE): Take a look at the product Avistat-D

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	3
Posts	843
Boards Moderated	0
Alias Born	08/10/2017

5bjjamie5

Re: None

Thursday, 09/24/2020 12:01:48 PM

Thursday, September 24, 2020 12:01:48 PM

Take a look at the product Avistat-D

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent PURE News

Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:30:15 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 01/10/2024 09:30:10 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/19/2023 09:45:12 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/14/2023 09:10:35 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:05:40 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/30/2023 08:10:52 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:05:19 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:23:02 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:20:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:19:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:17:13 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:15:37 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:14:38 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/03/2023 08:13:14 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2023 08:30:36 PM

More PURE News

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover